Study | Study Type | Sample Size, n | Mean Age, years | Cardiovascular Risk Factors (%) | Intervention | Mean Follow up (months) |
De Souza et al.23 | Retrospective Cohort | 48 | 29 | 92 | ASA: 28 ASA + clopidogrel: 1 Ticlopidine: 1 AC: 6 | 76.5 |
Berger et al.24 | Cross-sectional | 85 | 73 | 79 | ASA: 22 AC:7 | n/a |
Salvarani et al.25 | Cross-sectional | 180 | 74 | 65* | ASA:21 Ticlopidine: 3 AC: 2 | n/a |
Narvaez et al.26 | Retrospective Cohort | 121 | 74 | 34 | ASA: 30 Ticlopidine: 3 Clopidogrel: 4 AC: n/a | 43.2 |
Lee et al.27 | Retrospective Cohort | 143 | 74 | 69 | ASA/clopidogrel/AC: 86 | 50.1 |
Nesher et al.28 | Retrospective Cohort | 175 | 74 | 24 | ASA: 36 AC: 3 | 26.4 |
Gonzalez-Gay et al.29 | Cross sectional | 210 | 75 | 33* | ASA: 11 Triflusal: 3 AC: 1 | n/a |